Gray Market Peptides: So Much Hype, So Little Data (Medscape)

Medscape spoke to Pinchas Cohen about the popularity of peptide supplementation despite the lack of rigorous evidence supporting the practice. He noted that he has testified before the FDA multiple times as an expert on other drugs, including human growth hormone, but no one has asked him to present on MOTS-c so far. If they did, he would advise against FDA deregulation at this time and instead appeal for research funding and accelerated clinical trials, he added.